dc.contributor.author | Rajabi, H | |
dc.contributor.author | Ahmad, R | |
dc.contributor.author | Jin, C | |
dc.contributor.author | Kosugi, M | |
dc.contributor.author | Alam, M | |
dc.contributor.author | Joshi, MD | |
dc.contributor.author | Kufe, D | |
dc.date.accessioned | 2013-07-30T13:37:53Z | |
dc.date.available | 2013-07-30T13:37:53Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | J Biol Chem. 2012 Mar 23;287(13):10703-13. doi: 10.1074/jbc.M111.323311. Epub 2012 Feb 8. | en |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/22318732 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/52658 | |
dc.description.abstract | MUC1 is a heterodimeric glycoprotein that is overexpressed in breast cancers. The present studies demonstrate that the oncogenic MUC1 C-terminal subunit (MUC1-C) associates with the TCF7L2 transcription factor. The MUC1-C cytoplasmic domain (MUC1-CD) binds directly to the TCF7L2 C-terminal region. MUC1-C blocks the interaction between TCF7L2 and the C-terminal-binding protein (CtBP), a suppressor of TCF7L2-mediated transcription. TCF7L2 and MUC1-C form a complex on the cyclin D1 gene promoter and MUC1-C promotes TCF7L2-mediated transcription by the recruitment of β-catenin and p300. Silencing MUC1-C in human breast cancer cells down-regulated activation of the cyclin D1 promoter and decreased cyclin D1 expression. In addition, a MUC1-C inhibitor blocked the interaction with TCF7L2 and suppressed cyclin D1 levels. These findings indicate that the MUC1-C oncoprotein contributes to TCF7L2 activation and thereby promotes cyclin D1 expression in breast cancer cells. | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi | en |
dc.title | MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells. | en |
dc.type | Article | en |
local.publisher | Faculty of medicine | en |